Hereditary Cancer Unit

What does the Unit treat?

At HM CIOCC, our Cardio-Oncology Unit is dedicated to protecting the cardiovascular health of cancer patients. We understand that oncological treatments can have side effects on the heart, and therefore we offer a comprehensive approach to the prevention, early detection, and management of cardiotoxicity.

What makes us different?

• Comprehensive approach: We monitor the cardiovascular health of our patients from the beginning of oncological treatment.
• Early detection: We use advanced techniques, such as MyoStrain, to detect cardiac toxicity in its earliest stages.
• Top-level team: We have a team of highly specialized cardiologists and oncologists in cardio-oncology.

Related Diseases

All types of cancer where treatment can cause cardiotoxicity, including:

• Breast cancer (trastuzumab, anthracyclines).
• Lymphomas (anthracyclines).
• Leukemias (anthracyclines).
• Sarcomas (anthracyclines).
• Etc.

Cardiovascular conditions that can be exacerbated by cancer treatment, including:

• Heart failure.
• Arrhythmias.
• Ischemic heart disease.
• Hypertension.
• Valvular heart disease.

Who is it for?

• Cancer patients who are about to start or are already undergoing treatment with chemotherapy, radiotherapy, or targeted therapies.
• Cancer patients with pre-existing cardiovascular conditions.
• Cancer survivors with a history of cardiotoxicity.
• People at high risk of developing cancer who wish to proactively manage their cardiovascular health.

What do we offer?

• Cardiovascular evaluation before, during, and after oncological treatment.
• Comprehensive approach: We monitor the cardiovascular health of our patients from the beginning of oncological treatment.
• Early detection: We use advanced techniques, such as MyoStrain, a non-invasive cardiac magnetic resonance imaging technique that allows detecting subtle changes in heart muscle function, even before symptoms or changes appear in conventional tests.
• Top-level team: We have a team of highly specialized cardiologists and oncologists in cardio-oncology.